Searched for
GENERIC DRUGS
Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...07 Nov, 2026, 05.39 PM IST- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...05 Nov, 2026, 11.49 AM IST
- Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in BrazilDr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be avai...05 Nov, 2026, 10.19 AM IST
- Alkem Laboratories appoints Amrut Naik as CEOAlkem Laboratories announced the appointment of Amrut Naik as its new Chief Executive Officer. His appointment is effective from November 1...03 Nov, 2026, 04.55 PM IST
- Sun Pharma’s specialty portfolio, Organon deal to drive growthSun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines....02 Nov, 2026, 06.48 AM IST
- India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugsOver the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...02 Nov, 2026, 12.07 AM IST
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...31 Oct, 2026, 11.47 PM IST
- Sun Pharma Q2 profit takes a hit on exceptional itemsSun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue ...31 Oct, 2026, 09.31 AM IST
- Sun Pharma Q2 profit falls 36% as litigation costs hit earningsSun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Reven...30 Oct, 2026, 10.14 PM IST
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...30 Oct, 2026, 01.13 AM IST
- India's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: PharmexcilIndia's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...29 Oct, 2026, 09.03 PM IST
- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...29 Oct, 2026, 11.46 AM IST
- Cancer care can be cheaper: 6 steps to cut drug costsIndia has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...28 Oct, 2026, 11.47 PM IST
- Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker No...27 Oct, 2026, 03.41 PM IST
- Cipla expects US business to draw support from upcoming product pipelineCipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fe...27 Oct, 2026, 03.09 PM IST
- Dr Reddy's bets on generic semaglutide, biosimilarsDr Reddy's domestic formulations business grew in the September quarter, while Revlimid sales declined in North America. A relaunch of gene...26 Oct, 2026, 01.19 AM IST
- Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...23 Oct, 2026, 03.19 PM IST
Load More
